Article Versions Notes

Buchholz SM, Nause N, König U, Reinecke J, Steuber B, Ammer-Herrmenau C, Reuter-Jessen K, Bohnenberger H, Biggemann L, Braulke F, et al. Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology. Journal of Personalized Medicine. 2023; 13(12):1701. https://doi.org/10.3390/jpm13121701

Buchholz, Soeren M., Nelia Nause, Ute König, Johanna Reinecke, Benjamin Steuber, Christoph Ammer-Herrmenau, Kirsten Reuter-Jessen, Hanibal Bohnenberger, Lorenz Biggemann, Friederike Braulke, and et al. 2023. "Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology" Journal of Personalized Medicine 13, no. 12: 1701. https://doi.org/10.3390/jpm13121701

Buchholz, S. M., Nause, N., König, U., Reinecke, J., Steuber, B., Ammer-Herrmenau, C., Reuter-Jessen, K., Bohnenberger, H., Biggemann, L., Braulke, F., Neesse, A., Ellenrieder, V., Ströbel, P., Adler, M., & König, A. (2023). Time to Deliver on Promises: The Role of ERBB2 Alterations as Treatment Options for Colorectal Cancer Patients in the Era of Precision Oncology. Journal of Personalized Medicine, 13(12), 1701. https://doi.org/10.3390/jpm13121701